LYN and chronic myelogenous leukemia, BCR-ABL1 positive: In this study, we applied the MIB/MS strategy to investigate kinome adaptations in a cell line model of Lyn-driven, imatinib-resistant CML (MYL-R) and compared this to its imatinib-sensitive counterpart (MYL) [22].